Compare IMNM & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | TRN |
|---|---|---|
| Founded | 2006 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2020 | 1994 |
| Metric | IMNM | TRN |
|---|---|---|
| Price | $28.01 | $29.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | $32.80 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 1.1M | 732.2K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | 51.40 | ★ 85.98 |
| EPS | N/A | ★ 1.50 |
| Revenue | $6,941,000.00 | ★ $2,156,900,000.00 |
| Revenue This Year | N/A | $1.91 |
| Revenue Next Year | $1,127.34 | $15.61 |
| P/E Ratio | ★ N/A | $19.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.67 | $24.76 |
| 52 Week High | $30.06 | $38.31 |
| Indicator | IMNM | TRN |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 36.02 |
| Support Level | $18.72 | $28.81 |
| Resistance Level | N/A | $30.32 |
| Average True Range (ATR) | 1.51 | 0.89 |
| MACD | 0.15 | 0.04 |
| Stochastic Oscillator | 66.25 | 26.44 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.